Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/82068
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDeane, A.en
dc.contributor.authorHorowitz, M.en
dc.date.issued2014en
dc.identifier.citationDiabetes Care, 2014; 37(2):e40-e41en
dc.identifier.issn0149-5992en
dc.identifier.issn1935-5548en
dc.identifier.urihttp://hdl.handle.net/2440/82068-
dc.description.statementofresponsibilityAdam M. Deane and Michael Horowitzen
dc.language.isoenen
dc.publisherAmerican Diabetes Associationen
dc.rights© 2014 by the American Diabetes Associationen
dc.subjectHumans; Diabetes Mellitus, Type 2; Receptors, Glucagon; Incretinsen
dc.titleComment. Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes?en
dc.typeJournal articleen
dc.identifier.rmid0030000160en
dc.identifier.doi10.2337/dc13-1616en
dc.identifier.pubid64166-
pubs.library.collectionAnaesthesia and Intensive Care publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
Appears in Collections:Anaesthesia and Intensive Care publications

Files in This Item:
File Description SizeFormat 
hdl_82068.pdfAccepted version120.43 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.